Demerger

Hier finden Sie alle Informationen zum Thema Demerger.

A headache for Bayer? Shareholder activist stands for election to the Supervisory Board.

Activist shareholder expected to join Bayer Supervisory Board

Jeffrey Ubben will be the first shareholder activist to join Bayer's Supervisory Board if the vote goes as expected at the AGM on April 26. The proxy advisors have no objections to his appointment.Show more

Heated debates expected after share price debacle

von Annette Becker

Helen Giza, Chief Executive Officer of Fresenius Medical Care

FMC makes progress in its transformation

Following its demerger from the Fresenius Group, dialysis specialist Fresenius Medical Care (FMC) is stepping up its efforts to reduce costs and streamline its portfolio. The MDax company is also aiming to make significant gains in its operating performance in the current year.Show more

Medical technology

von Sabine Wadewitz

Unilever hätte mehr gezahlt

GlaxoSmithKline hat ihr Consumer-Health-Geschäft Haleon in London an die Börse gebracht. Die Marktkapitalisierung blieb hinter den 50 Mrd. Pfund zurück, die Unilever für die Sparte zahlen wollte.Show more

Haleon-Listing

von Andreas Hippin